The EveryLife Foundation for Rare Diseases delivered letters of support for the Speeding Therapy Access Today Act of 2021 H.R. 1730/S. 670, or STAT Act, signed by 110 rare disease partners. The letters were delivered to Committtee leadership as well as the bill’s lead sponsors in the House and Senate earlier this week.
The bill, introduced in March, proposes targeted, impactful and attainable policy reforms at the FDA that will accelerate development of and access to therapies across the spectrum of rare diseases.
The EveryLife Foundation has left the support letter open for new signors who may not have had a chance to sign the initial letter.
Visit the STAT Act website at www.statact.org to learn more about the bill, get updates and access downloadable partner tools.
View the support letter to Committee leadership.
View the support letter to lead sponsors.
